Description
Quantitative determination of specific antibodies in the blood, class E immunoglobulins, appearing in the presence of an allergic reaction to grey alder pollen. This analysis is used: for the diagnosis of allergic diseases (bronchial asthma, allergic rhinitis, respiratory allergosis); to assess the risk of developing allergic reactions to grey alder pollen. This analysis is prescribed: in the presence of the following symptoms indicating an allergic nature: redness and burning of the eye mucous membrane, lacrimation and eyelid edema, nasal congestion, sneezing, cough, shortness of breath, bronchospasm, etc.; during exacerbation of symptoms in the flowering period of grey alder; with a polyvalent nature of sensitization, when it is not possible to conduct in vivo testing with suspected allergens; in case of false positive or false negative skin testing results; to children if their parents suffer from allergic diseases, including those manifesting in the spring-summer period.
Period of execution
Within 3 days. The specified time does not include the day of biomaterial collection
Biomaterial type